MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

24.51 -14.60 (-37.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,814,042
Open 23.85
Bid (Size) 24.64 (100)
Ask (Size) 24.86 (100)
Prev. Close 39.11
Today's Range 22.47 - 26.00
52wk Range 8.730 - 71.50
Shares Outstanding 54,865,673
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
uniQure BLA Filed as AMT-130 Shows 4-Year Huntington’s Functional Benefit ↗
uniQure (NASDAQ:QURE) reported updated Phase I/II data for its investigational Huntington’s disease gene therapy, ifezuntirgene inilparvovec, or AMT-130, including 36-month results from all high-dose... 
Via MarketBeat
Top movers analysis one hour before the close of the markets on 2026-09-29: top gainers and losers in today's session. ↗
Via Chartmill

Performance

YTD
+4.8%
+4.8%
1 Month
-49.7%
-49.7%
3 Month
-46.8%
-46.8%
6 Month
+49.9%
+49.9%
1 Year
-58.7%
-58.7%

More News

Read More
News headline image
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
UniQure (NASDAQ:QURE) Rises on Pipeline Progress Despite Wider Q2 Loss ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
News headline image
QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
From Kehoe Law Firm
Via GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure (QURE) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
uniQure Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure to Announce Second Quarter 2026 Financial Results
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Pricing of Upsized $225 Million Public Offering
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces $150 Million Proposed Public Offering
From uniQure Inc.
Via GlobeNewswire
News headline image
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗
Via InvestorPlace
News headline image
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
From uniQure Inc.
Via GlobeNewswire
Top movers in Wednesday's session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?
Yes, uniQure N.V. - Ordinary Shares is publicly traded.
What exchange does uniQure N.V. - Ordinary Shares trade on?
uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for uniQure N.V. - Ordinary Shares?
The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
What is the current price of uniQure N.V. - Ordinary Shares?
The current price of uniQure N.V. - Ordinary Shares is 24.51
When was uniQure N.V. - Ordinary Shares last traded?
The last trade of uniQure N.V. - Ordinary Shares was at 09/29/26 04:00 PM ET
What is the market capitalization of uniQure N.V. - Ordinary Shares?
The market capitalization of uniQure N.V. - Ordinary Shares is 1.34B
How many shares of uniQure N.V. - Ordinary Shares are outstanding?
uniQure N.V. - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story